SMAD3 and Insulin resistance: In conclusion, as mentioned earlier, GDF-15 could have an adverse effect on sarcopenia and decrease skeletal muscle mass by activating FOXO1 and SMAD3, however, its protecting role against insulin resistance could reverse the process of sarcopenia.